Unilever's offer for GSK's Sensodyne and Advil raises doubts

Unilever faces a dilemma after its 50 billion pound ($68 billion) offer for GlaxoSmithKline's consumer healthcare assets was rejected

Related Keywords

Alan Jope ,Bruno Monteyne ,Reckitt Beckiser Mead Johnson ,James Targett ,Jeremy Fialko ,Danone Whitewave ,Bernstein Monteyne ,Glaxosmithkline ,Unilever ,Dollar Shave Club ,Consumer Health ,Executive Alan Jope ,Reckitt Beckiser ,Mead Johnson ,